Why does congestive heart failure and chronic obstructive pulmonary disease slow drug distribution?

Congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) can slow drug distribution due to impaired blood flow and reduced oxygenation in the body. In CHF, decreased cardiac output leads to diminished perfusion of tissues, affecting how quickly drugs reach their target sites. Similarly, COPD can result in poor gas exchange and limited blood flow in the lungs, further hindering drug absorption and distribution. These conditions can lead to altered pharmacokinetics, necessitating adjustments in drug dosing and monitoring.